these results may support the idea that an abnormal release of pdgf occurs from platelets or megakaryocytes in the bone marrow environment , resulting in the stimulation of fibroblast proliferation , and hence , the occurrence of myelofibrosis in patients with mpd .
C0001815
myelofibrosis
C0027022
mpd